Department of Urology, The Third Affiliated Hospital of Nanjing Medical University (Changzhou Second People's Hospital), Changzhou, China.
Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi, China.
J Cell Physiol. 2024 Nov;239(11):e31412. doi: 10.1002/jcp.31412. Epub 2024 Aug 16.
Nuclear protein-1 (NUPR1) (also known as p8) is one of the genes associated with transcription factors that participate in various aspects of cancer initiation and development. However, the molecular mechanisms of NUPR1 in bladder cancer (BLCA) remain unclear. We conducted an analysis of the correlation between NUPR1 expression and related genes using the Gene Expression Omnibus (GEO) online database. We employed lentivirus-mediated small interfering RNA (siRNA) to knockdown the expression of NUPR1 in two human BLCA cell lines. In vitro experiments were conducted to validate the impact of NUPR1 interference on BLCA and the influence of NUPR1 on the transcription of chemokine receptor-2 (CCR2). Furthermore, transcription factors for CCR2 were predicted using the PROMO database. Co-immunoprecipitation (Co-IP) and immunofluorescence double staining were used to detect the binding between NUPR1 and CCAAT/enhancer binding protein γ (CEBPG). In vivo and in vitro experiments were conducted to validate that NUPR1 regulates CCR2 transcription through CEBPG. In vitro experiments indicate that the suppression of NUPR1 inhibited BLCA growth. Analysis of the GEO database revealed a positive correlation between the expression of NUPR1 and CCR2. Luciferase experiments confirmed that NUPR1 influences the transcription of CCR2. Online data indicates that CEBPG is a transcription factor for CCR2. Co-IP and immunofluorescence double staining confirmed binding between NUPR1 and CEBPG. Luciferase assays and chromatin immunoprecipitation (ChIP) demonstrate that CEBPG regulates the transcription of CCR2. Additionally, rescue experiments at the cellular level and animal experiments validated the aforementioned mechanism. NUPR1 promotes a promotional role in BLCA, and interference with NUPR1 can inhibit the proliferation and invasive abilities of BLCA. There was a correlation between the expressions of NUPR1 and CCR2, and NUPR1 binds with CEBPG in the cell nucleus. Transcriptional regulation of CCR2 by NUPR1 may be achieved through the involvement of CEBPG.
核蛋白 1(NUPR1)(也称为 p8)是与参与癌症发生和发展的各个方面的转录因子相关的基因之一。然而,NUPR1 在膀胱癌(BLCA)中的分子机制尚不清楚。我们使用基因表达综合数据库(GEO)在线数据库分析了 NUPR1 表达与相关基因的相关性。我们使用慢病毒介导的小干扰 RNA(siRNA)敲低两种人 BLCA 细胞系中的 NUPR1 表达。进行了体外实验以验证 NUPR1 干扰对 BLCA 的影响以及 NUPR1 对趋化因子受体 2(CCR2)转录的影响。此外,使用 PROMO 数据库预测了 CCR2 的转录因子。使用共免疫沉淀(Co-IP)和免疫荧光双重染色检测 NUPR1 与 CCAAT/增强子结合蛋白 γ(CEBPG)之间的结合。进行了体内和体外实验以验证 NUPR1 是否通过 CEBPG 调节 CCR2 转录。体外实验表明,抑制 NUPR1 抑制了 BLCA 的生长。GEO 数据库的分析表明,NUPR1 的表达与 CCR2 呈正相关。荧光素酶实验证实 NUPR1 影响 CCR2 的转录。在线数据表明 CEBPG 是 CCR2 的转录因子。Co-IP 和免疫荧光双重染色证实了 NUPR1 与 CEBPG 的结合。荧光素酶测定和染色质免疫沉淀(ChIP)表明 CEBPG 调节 CCR2 的转录。此外,细胞水平的挽救实验和动物实验验证了上述机制。NUPR1 促进 BLCA 的促进作用,干扰 NUPR1 可以抑制 BLCA 的增殖和侵袭能力。NUPR1 和 CCR2 的表达之间存在相关性,并且 NUPR1 在细胞核中与 CEBPG 结合。NUPR1 对 CCR2 的转录调节可能是通过 CEBPG 实现的。